Publications
123
Citations
3,462
Est. group size
—
Recurring co-author estimate
Active years
31
Publishing since 1996
This publication record appears to combine work from multiple researchers sharing the name Huijuan Song, spanning infectious disease diagnostics (tuberculosis, sepsis, CRE infections), cancer biology and oncology trials, and mathematical modeling of tumor growth using partial differential equations. Topics include machine learning approaches to distinguish active from latent tuberculosis, immune profiling in sepsis, drug development for viral infections, and theoretical models of tumor growth with free boundaries. Prospective students should note the unusually broad and disconnected topic spread, which may indicate name overlap across distinct research groups rather than a single coherent research program.
Publication output peaked around 2020-2021 with 16-17 papers per year, then declined to a steadier pace of roughly 4-7 papers per year through 2022-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- The dynamic changes of postoperative symptoms in lower limb Ilizarov bone transport patients: a longitudinal cross-lagged panel network analysis
BMC Musculoskeletal Disorders · 2026
- A Novel Approach for Recognizing Fine Fractures in Hydraulic Fracturing of Rock Core
IEEE Access · 2025
- Risk Factor Analysis of CRE Infections at Different Anatomical Sites in ICU Patients
Antibiotics · 2025
- 846TiP Fixed-duration orelabrutinib plus bendamustine and rituximab versus continuous Bruton Tyrosine Kinase inhibitor (BTKi) in treatment-naïve chronic/small lymphocytic leukemia (CLL/SLL): A multicenter, nonrandomized, pragmatic clinical trial
Annals of Oncology · 2024
- Linear stability for a free boundary problem modeling the growth of tumor cord with time delay
Mathematical Biosciences & Engineering · 2024
- Global existence of solutions for a free‐boundary tumor model with angiogenesis and a necrotic core
Mathematical Methods in the Applied Sciences · 2024
- Roles of cathepsin S expression levels on the prognosis and tumour microenvironment in clear cell renal cell carcinoma
Discover Oncology · 2024
- Using immune clusters for classifying Mycobacterium tuberculosis infection
International Immunopharmacology · 2024
- Identification of dihydroquinolizinone derivatives with nitrogen heterocycle moieties as new anti-HBV agents
European Journal of Medicinal Chemistry · 2024
- The immune landscape of sepsis and using immune clusters for identifying sepsis endotypes
Frontiers in Immunology · 2024
- The Immune Landscape of Sepsis and Using Immune Clusters for Identifying Sepsis Endotypes
SSRN Electronic Journal · 2023
- 693P Preclinical activity of HLX43, a PD-L1-targeting ADC, in multiple PD-1/PD-L1 refractory/resistant models
Annals of Oncology · 2023
- Remdesivir Derivative VV116 Is a Potential Broad-Spectrum Inhibitor of Both Human and Animal Coronaviruses
Viruses · 2023
- Convolutional neural network based on T-SPOT.TB assay promoting the discrimination between active tuberculosis and latent tuberculosis infection
Diagnostic Microbiology and Infectious Disease · 2023
- The pathogenic and clinical characteristics of severe fever with thrombocytopenia syndrome patients with co-infections
Frontiers in Cellular and Infection Microbiology · 2023
- Frontiers in Immunology×8
- arXiv (Cornell University)×5
- Kidney International Reports×4
- Journal of the American Society of Nephrology×4
- International Journal of Infectious Diseases×3
- Jessica Greco
Medicine · The Ohio State University
- B.H. Rovin
Medicine · The Ohio State University
- Stacy P. Ardoin
Medicine · The Ohio State University
- E. Grau Garcia
Medicine · Indiana University
- Haichang Li
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile